Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study.
Allergy
; 73(9): 1871-1880, 2018 Sep.
Article
in En
| MEDLINE
| ID: mdl-29688579
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Plasma Kallikrein
/
Enzyme Inhibitors
/
Angioedemas, Hereditary
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Allergy
Year:
2018
Type:
Article
Affiliation country:
United States